Completed PHASE3 INTERVENTIONAL 2-arm NCT02523820

Nebulized Corticosteroid for Post Extubation Stridor in Children

Nebulized Corticosteroid for Post Extubation Stridor in Children: A Randomized Double Blind Controlled Trial

Sponsor: Ramathibodi Hospital

Conditions Stridor

Interventions Placebo fluticasone propionate

Updated 7 times since 2017 Last updated: Apr 25, 2017 Started: Jan 31, 2015 Primary completion: May 30, 2016 Completion: Aug 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Stridor, this trial is completed. The trial is conducted by Ramathibodi Hospital and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
May 2017 — Jun 2018 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — May 2017 [monthly]

Recruiting PHASE3
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE3

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ramathibodi Hospital

Data source: Ramathibodi Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bangkok, Thailand